Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
114

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Anifrolumab use in pregnancy: maternal and neonatal outcomes in patients with systemic lupus erythematosus.

EULAR rheumatology open·2026
Same author

Spatial transcriptomics identifies immune-stromal niches associated with cancer in adult dermatomyositis.

Nature communications·2026
Same author

Spatial transcriptomics identifies cytotoxic and fibrotic immune-stromal niches in morphea and eosinophilic fasciitis.

The Journal of investigative dermatology·2026
Same author

Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.

Clinical, cosmetic and investigational dermatology·2026
Same author

Presentation, Diagnosis, and Treatment of Cutaneous Crohn Disease.

JAMA dermatology·2026
Same author

GLP-1 Receptor Agonist Therapy in Patients With Extragenital Lichen Sclerosus.

JAMA dermatology·2026

相关实验视频

Updated: Jun 7, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:38

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

35

在皮肤肌肉炎的创新.

Kimberly B Hashemi1, Katharina S Shaw2, Rochelle Castillo1

  • 1Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA; Dermatology Program, Division of Immunology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Autoimmune Skin Disease Program, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.

Dermatologic clinics
|November 14, 2024
PubMed
概括

皮肤肌肉炎 (DM) 是一种罕见的自身免疫性疾病,具有皮肤症状,癌症风险和器官干扰. 了解自身抗体和免疫驱动力的进步正在为新的向治疗铺平道路.

关键词:
皮肤性皮肤肌肉性肌肉性炎症皮肤肌肉菌性炎 (dermatomyositis) 是一种疾病.新兴的治疗方法干扰素 干扰素 干扰素肌肉炎特异性抗体 肌肉炎特异性抗体

更多相关视频

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.6K
Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding
09:14

Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding

Published on: August 22, 2016

12.4K

相关实验视频

Last Updated: Jun 7, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:38

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

35
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.6K
Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding
09:14

Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding

Published on: August 22, 2016

12.4K

科学领域:

  • 类风湿病学 类风湿病学
  • 免疫学 免疫学 免疫学
  • 皮肤病学 皮肤病学

背景情况:

  • 皮肤肌肉炎 (DM) 是一种罕见的自身免疫性疾病.
  • 它表现为特有的皮肤表现,增加癌症风险,以及肌肉,肺部,心脏,胃肠道和关节的潜在参与.
  • 目前尚不完全了解DM的确切病原体.

研究的目的:

  • 审查当前对皮肤肌肉性炎病原体的理解.
  • 突出肌肉炎特异性自身抗体在理解疾病异质性和风险分层方面的重要性.
  • 讨论最近免疫学发现对DM新疗法开发的影响.

主要方法:

  • 关于皮肤肌炎研究近期进展的文献综述.
  • 分析自身抗体在DM分类和预后中的作用.
  • 检查涉及DM的新兴免疫路径.

主要成果:

  • 肌肉炎特异性自身抗体有助于对DM亚型进行分类,并预测皮肤外表现和恶性瘤风险.
  • 已经确定了DM的主要免疫驱动因素.
  • 这些发现对于开发有针对性的疗法至关重要.

结论:

  • 通过自身抗体了解DM异质性对于风险评估至关重要.
  • 阐明DM的免疫基础正在加速新治疗方法的开发.
  • 未来的研究方向重点是针对DM的向免疫疗法.